Omeros | OMER - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Adma Biologics USD 136.02M 2.13M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Cytokinetics USD 255.27M 125.43M 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
Heron Therapeutics USD 20.72M 5.4M 2026-06
Immunic USD 186.63M 171.15M 2026-03
Insmed USD 544.76M 37.42M 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
MacroGenics USD 113.91M 47.39M 2026-06
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 205.88M 61.57M 2026-06
Pfizer USD 976M 727M 2026-06
Rockwell Medical USD 12.48M 1.09M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
United Therapeutics USD 1.8B 523.5M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06